Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2024-10-12 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 4.07 -242
2024-10-12 ABSI / Absci Corporation 4 Bedrick Todd F - Taxes D 4.07 -15,606
2024-10-02 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 3.71 -21,607
2024-10-02 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 21,607
2024-10-02 INCY / Incyte Corporation 4 Denton Sheila A. F - Taxes D 67.63 -2,136
2024-10-01 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 3.78 -26,082
2024-10-01 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 26,082
2024-10-01 ONMD / OneMedNet Corporation 4 McCraw Sherry Coonse A - Award D 11,342
2024-10-01 ONMD / OneMedNet Corporation 4 Yu Jeffrey A - Award D 0.57 230,769
2024-10-01 INCY / Incyte Corporation 4 Heeson Lee A - Award D 26,447
2024-10-01 ONMD / OneMedNet Corporation 4 Clarke Jair A - Award D 11,342
2024-09-30 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 71
2024-09-30 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 78
2024-09-30 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 62
2024-09-30 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 496
2024-09-30 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 66.10 378
2024-09-30 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 66.10 368
2024-09-30 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 496
2024-09-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.820 -3,000
2024-09-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 3,000
2024-09-20 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.66 1,600
2024-09-18 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.68 800
2024-09-16 MXCT / MaxCyte, Inc. 4 Soleymannezhad Ali A - Award D 10,400
2024-09-13 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 63.37 -382
2024-09-12 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 62.94 -572
2024-09-12 INCY / Incyte Corporation 4 Dickinson Jonathan Elliott S - Sale D 62.37 -7,333
2024-09-12 INCY / Incyte Corporation 4 Dickinson Jonathan Elliott S - Sale D 62.30 -1,117
2024-09-04 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 3.97 -29,767
2024-09-04 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 29,767
2024-09-03 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 4.10 -17,922
2024-09-03 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 17,922
2024-09-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -1,666
2024-08-31 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 4.40 -20,775
2024-08-30 ONMD / OneMedNet Corporation 4 Golden Robert Lawrence A - Award D 100,000
2024-08-27 IQV / IQVIA Holdings Inc. 4 Sherbet Eric S - Sale D 246.33 -1,300
2024-08-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 4.28 -3,000
2024-08-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 3,000
2024-08-23 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. S - Sale D 390.73 -3,774
2024-08-23 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 42.62 3,774
2024-08-22 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. S - Sale D 390.73 -4,353
2024-08-22 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 42.62 4,353
2024-08-21 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 1.22 100
2024-08-16 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 1.41 14
2024-08-15 NEO / NeoGenomics, Inc. 4 Olivo Alicia C S - Sale D 16.0533 -1,040
2024-08-15 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 1.34 10
2024-08-15 NEO / NeoGenomics, Inc. 4 Smith Christopher M F - Taxes D -33,130
2024-08-14 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 1.35 13
2024-08-14 ONMD / OneMedNet Corporation 4 Zeinfeld Andrew B A - Award D 17,260
2024-08-13 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 1.19 2,237
2024-08-12 INCY / Incyte Corporation 4 Stein Steven H S - Sale D 60.63 -11,608
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)